Central VetPharma Consultancy ApS: Financial statements 2020
CVR: 38773984
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Central VetPharma Consultancy ApS (CVR 38773984) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,540,760 and a net result of DKK 1,026,676 compared with DKK 1,018,927 the year before. That is a decrease of 12.1% compared with the year before. Equity in the 2020 report amounted to DKK 3,169,383. The solvency ratio was 89.3%.
- Gross Profit
- DKK 1,540,760
- Profit/Loss
- DKK 1,026,676
- Equity
- DKK 3,169,383
- Total Assets
- DKK 3,547,227
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.5 mio. | 1 mio. | 3.2 mio. | - |
| 2019 | - | 1.8 mio. | 1 mio. | 2.3 mio. | - |
| 2018 | - | 1.4 mio. | 543 t. | 1.3 mio. | - |
| 2017 | - | 1.4 mio. | 652 t. | 905 t. | 1 |
Official annual report
How creditworthy is Central VetPharma Consultancy ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Central VetPharma Consultancy ApS has published its annual report for 2019. Gross profit came to DKK 1,752,348, and the net result was DKK 1,018,927.
About Central VetPharma Consultancy ApS
Central VetPharma Consultancy ApS is a Danish company of the type Anpartsselskab based in Sorø, founded in 2017. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Anja Elisabeth Houlberg Holm. The company is owned by Anja Elisabeth Houlberg Holm. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,620,579 and a net result of DKK 719,033 compared with DKK 479,115 the year before. Equity in the 2025 report amounted to DKK 4,658,412.